News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,284 Results
Type
Article (40846)
Company Profile (272)
Press Release (685157)
Multimedia
Podcasts (150)
Webinars (29)
Section
Business (233072)
Career Advice (2377)
Deals (36964)
Drug Delivery (211)
Drug Development (80363)
Employer Resources (174)
FDA (16505)
Job Trends (15327)
News (343213)
Policy (30984)
Tag
2025 Best Places to Work (20)
2026 Best Places to Work (31)
2027 BioCapital Standard (4)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (1973)
Academic (1)
Accelerated approval (68)
ADA (48)
Adcomms (29)
Allergies (223)
Alliances (48596)
ALS (277)
Alzheimer's disease (1967)
Antibody-drug conjugate (ADC) (734)
Approvals (17172)
Artificial intelligence (1001)
ASCO (335)
Autoimmune disease (521)
Automation (75)
Bankruptcy (386)
Belgium (44)
Best Places to Work (11279)
BIO (82)
Biologics (112)
BIOSECURE Act (23)
Biosimilars (287)
BioSpace Insights (137)
Biotechnology (185)
Bispecific (60)
Bladder cancer (241)
Brain cancer (93)
Breast cancer (881)
Cancer (7499)
Cardiovascular disease (629)
Career advice (2030)
Career pathing (59)
CAR-T (431)
CDC (46)
CDMO (220)
Celiac Disease (6)
Cell therapy (1159)
Cervical cancer (62)
Clinical research (72338)
Collaboration (2770)
Commercialization (72)
Company closure (9)
Compensation (1894)
Complete response letters (121)
COVID-19 (2654)
CRISPR (146)
CRO (7)
C-suite (1678)
Cystic fibrosis (174)
Data (10804)
Decentralized trials (4)
Denatured (25)
Depression (217)
Dermatology (191)
Diabetes (770)
Diagnostics (7503)
Digital health (76)
Diversity (8)
Diversity, equity & inclusion (40)
Drug discovery (484)
Drug pricing (224)
Drug shortages (33)
Duchenne muscular dystrophy (367)
Earnings (91818)
Editorial (77)
Employer branding (25)
Employer resources (161)
ESMO (430)
Events (123957)
Executive appointments (1341)
Eye disease (25)
FDA (21408)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (5)
Friedreich's ataxia (29)
Frontotemporal dementia (40)
Funding (2249)
Gene editing (302)
Generative AI (91)
Gene therapy (892)
GLP-1 (1271)
Government (3834)
Grass and pollen (8)
Guidances (428)
Healthcare (17956)
Hematology (215)
HIV (116)
Huntington's disease (90)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (152)
Immunology and inflammation (391)
Immuno-oncology (159)
Indications (292)
Infectious disease (3078)
Inflammatory bowel disease (266)
Inflation Reduction Act (14)
Influenza (156)
Intellectual property (381)
Interviews (474)
IPO (17537)
IRA (52)
Job creations (4300)
Job search strategy (1626)
JPM (65)
Kidney cancer (28)
Kidney disease (168)
Labor market (129)
Layoffs (701)
Leadership (63)
Legal (7825)
Licensing (124)
Liver cancer (112)
Longevity (50)
Lung cancer (1032)
Lung diease (25)
Lymphoma (527)
Machine learning (73)
Management (67)
Manufacturing (1563)
Marketing (39)
MASH (250)
Medical affairs (5)
Medical device (14659)
Medtech (14990)
Mergers & acquisitions (20972)
Metabolic disorders (1981)
Middle East (2)
mRNA (320)
Multiple sclerosis (254)
Multispecific (6)
NASH (21)
Netherlands (39)
Neurodegenerative disease (594)
Neuropsychiatric disorders (146)
Neuroscience (4070)
Neurotech (3)
NextGen: Class of 2026 (6227)
Non-profit (2998)
Now hiring (100)
Obesity (934)
Opinion (379)
Ovarian cancer (285)
Pain (332)
Pancreatic cancer (440)
Parkinson's disease (468)
Partnered (45)
Patents (789)
Patient advocacy (5)
Patient recruitment (977)
Patient selection (116)
Peanut (78)
People (62008)
Peptides (43)
Pharmaceutical (58)
Pharmacy benefit managers (41)
Phase 1 (22712)
Phase 2 (32221)
Phase 3 (23904)
Pipeline (14331)
Policy (359)
Postmarket research (2057)
Preclinical (9305)
Press Release (69)
Prostate cancer (388)
Psychedelics (96)
Radioligand (2)
Radiopharmaceuticals (436)
Rare diseases (1494)
Real estate (5990)
Recruiting (76)
Regenerative medicine (35)
Regulatory (26454)
Reports (69)
Research institute (1916)
Resumes & cover letters (380)
Rett syndrome (55)
RNA editing (34)
RSV (98)
Saudi Arabia (1)
Schizophrenia (220)
Series A (404)
Series B (281)
Service/supplier (10)
Sickle cell disease (139)
Special edition (36)
Spinal muscular atrophy (179)
Sponsored (50)
Startups (4021)
State (2)
Stem cells (8)
Stomach cancer (21)
Substance use disorders (23)
Supply chain (158)
Switzerland (22)
Tariffs (103)
Tax incentives (1)
The Weekly (123)
Vaccines (1278)
Venture capital (171)
Weight loss (602)
Wet AMD (6)
Women's health (167)
Women in leadership (1)
Worklife (26)
Date
Today (204)
Last 7 days (895)
Last 30 days (3732)
Last 365 days (32229)
2026 (29114)
2025 (30999)
2024 (35877)
2023 (41083)
2022 (51948)
2021 (55974)
2020 (53241)
2019 (44677)
2018 (33975)
2017 (33563)
2016 (32244)
2015 (37812)
2014 (30358)
2013 (25061)
2012 (26710)
2011 (26953)
2010 (24479)
Location
Africa (780)
Alabama (116)
Alaska (7)
Arizona (376)
Arkansas (14)
Asia (44469)
Australia (7263)
California (16830)
Canada (4624)
China (2004)
Colorado (728)
Connecticut (752)
Delaware (523)
Europe (98634)
Florida (2516)
Georgia (534)
Hawaii (4)
Idaho (62)
Illinois (1303)
India (152)
Indiana (767)
Iowa (35)
Japan (729)
Kansas (146)
Kentucky (63)
Louisiana (56)
Maine (94)
Maryland (1838)
Massachusetts (12224)
Michigan (432)
Minnesota (913)
Mississippi (8)
Missouri (179)
Montana (36)
Nebraska (28)
Nevada (198)
New Hampshire (88)
New Jersey (4450)
New Mexico (36)
New York (4303)
North Carolina (2159)
North Dakota (13)
Northern California (8758)
Ohio (484)
Oklahoma (25)
Oregon (47)
Pennsylvania (3232)
Puerto Rico (38)
Rhode Island (64)
South America (1153)
South Carolina (100)
South Dakota (2)
Southern California (6664)
Tennessee (252)
Texas (2745)
United States (58884)
Utah (498)
Vermont (2)
Virginia (401)
Washington D.C. (81)
Washington State (1324)
West Virginia (4)
Wisconsin (180)
Wyoming (5)
726,284 Results for "general electric company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Promega Achieves 100% Renewable Electricity Across Global Operations
July 28, 2026
·
2 min read
Obesity
Zealand pens up to $1.2B deal with Generate for AI-designed obesity, metabolic drugs
Obesity-focused Zealand Pharma is buying into Generate:Biomedicines’s generative AI platform to create new multispecific drug candidates.
October 14, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Galvanize Therapeutics Receives FDA Clearance for Aliya EX Generator, Expanding its Aliya Pulsed Electric Field Portfolio for Surgical Ablation of Soft Tissue
May 18, 2026
·
3 min read
Press Releases
Arboretum Launches to Redefine Precision Medicine for Common Diseases as a Next-Generation Molecular Information Company
October 6, 2026
·
6 min read
Press Releases
Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme
Progress demonstrates that BioHarvest’s Botanical Synthesis(TM) platform is capable of producing the targeted next-generation sweetening solution
October 8, 2026
·
6 min read
Press Releases
Renova Pharmaceuticals Announces First Three U.S. Generic Product Launches, Marking a Major Company Milestone
September 10, 2026
·
2 min read
Press Releases
Telo Genomics Reports Additional Clinical Research Results Comparing Blood-Based TELO-MRD with Bone-Marrow Next-Generation Flow and Next-Generation Sequencing
In matched Cleveland Clinic and Jewish General Hospital samples, blood-based TELO enumeration detected circulating plasma cells in all Adaptive clonoSEQ-positive cases reviewed and in a series of clonoSEQ-negative or non-evaluable samples; previously reported EuroFlow comparison data are also summarized.
September 29, 2026
·
8 min read
Press Releases
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
In matched multi-center cohorts, Telo Genomics is expanding comparative evaluation of blood-based TELO-MRD against Adaptive Biotechnologies’ clonoSEQ next-generation sequencing MRD testing.
October 29, 2026
·
6 min read
Press Releases
Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
September 14, 2026
·
10 min read
Drug Development
Generate Bio drops as data accidentally leaked ahead of European conference
Phase 1 data from Generate Biomedicines’ ongoing chronic obstructive pulmonary disease study demonstrated “rapid and sustained reductions” across four disease biomarkers.
August 27, 2026
·
2 min read
·
Gabrielle Masson
1 of 72,629
Next